Radiofrequency Nucleoplasty vs Percutaneous Nucleotomy vs Decompression Catheter in Lumbar Disc Herniation

May 2, 2022 updated by: The Cleveland Clinic

Radiofrequency Nucleoplasty vs Percutaneous Nucleotomy (Dekompressor) vs Decompression Catheter for the Treatment of Painful Contained Lumbar Disc Herniation: A Prospective Randomized Controlled Study

The purpose of this study is to learn which of three minimally invasive procedures is the most effective for treatment of contained lumbar disc herniation.

Study Overview

Detailed Description

Contained herniation of the lumbar intervertebral disc is a frequent cause of leg and back pain. Over the last decade, there is a tendency to shift from surgical treatment of the intervertebral disc including laminectomy/discectomy to an excess of nonoperative management. Three techniques introduced recently are used as minimally invasive treatments for decompression of contained herniation of the nucleus pulposus. Nucleoplasty uses Coblation® radiofrequency vaporization of nuclear tissue to decompress the intervertebral disc. Catheter disc decompression uses heat from a resistive coil positioned in the area of disc herniation while Dekompressor® uses volume reduction to decrease an intradiscal pressure.

This is a comparison study which investigates if intervertebral electrothermal disc decompression produces better pain relief measured on VAS scale, improvement in functional capacity, return to work and opioid use, than nucleoplasty or percutaneous disc decompression (Dekompressor) of the lumbar intervertebral disc in a prospective randomized controlled study. Patients will be randomized into four treatment groups in equal numbers. The first group will be treated using nucleoplasty, the second will receive Dekompressor® lumbar disc decompression, the third will receive thermal treatment using decompression catheter (Achutherm TM) and the forth will be the control group. The control group will be treated conservatively using medications including gabapentin, a breakthrough opioid (oxycodone 5 mg 1-2 tablets q 4-6 hours as needed), NSAID, epidural steroid injections and physical therapy.

Patients will be followed and assessed at one, three, six, nine and twelve months following the procedure using VAS scores, Oswestry and SF-36 Short Form questionnaires, opioid use and return to work evaluation.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 52 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • History of concordant radicular leg pain unresponsive to conservative treatment for longer than 3 months
  • Leg pain must be greater than back pain
  • Contained disc herniation as evidenced by MRI
  • No evidence of psychological issues by exam or history

Exclusion Criteria:

  • A score of greater than 10 on Beck Depression Inventory (BDI)
  • Patients with pending workers compensation claim or litigation
  • Pregnancy
  • Tumor
  • Systemic infection or localized infection at the anticipated entry needle site
  • Traumatic spinal fracture
  • History of coagulopathy
  • Unexplained bleeding
  • Progressive neurological deficits
  • History of opioid abuse or patients currently on long acting opioids
  • Patients presenting with moderate or severe lumbar central or lateral canal stenosis, free disc fragments or degenerative disc disease as described on MRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Nucleoplasty
Procedure/Surgery: Nucleoplasty
Active Comparator: Percutaneous decompression
Procedure/Surgery: Percutaneous decompression
Active Comparator: Electrothermal disc decompression (IDET)
Procedure/Surgery: Intervertebral electrothermal disc decompression (IDET)
Experimental: Behavioral:Conservative treatment
Conservative treatment with oral medications, physical therapy, epidural steroid injections

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
VAS pain evaluation score at baseline, 1, 3, 6, 9, 12 months
Time Frame: baseline 1, 3, 6, 9, 12 months
baseline 1, 3, 6, 9, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry results
Time Frame: baseline 1, 3, 6, 9, 12 months
Disability Index
baseline 1, 3, 6, 9, 12 months
Quality of Life SF-36
Time Frame: baseline 1, 3, 6, 9, 12 months
SF-36 score at baseline 1, 3, 6, 9, 12 months
baseline 1, 3, 6, 9, 12 months
Return to work evaluation
Time Frame: 1 month
Return to work evaluation
1 month
Depression score
Time Frame: BASELINE
Beck Depression Inventory score at pre-treatment visit
BASELINE
Opioid use
Time Frame: 1, 3, 6, 9, 12 months
Opioid use
1, 3, 6, 9, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Leonardo Kapural, MD, OhD, Cleveland Clinic Foundation, Pain Management Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2006

Primary Completion (Actual)

August 1, 2007

Study Completion (Actual)

August 1, 2007

Study Registration Dates

First Submitted

March 8, 2006

First Submitted That Met QC Criteria

March 8, 2006

First Posted (Estimate)

March 10, 2006

Study Record Updates

Last Update Posted (Actual)

May 3, 2022

Last Update Submitted That Met QC Criteria

May 2, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Herniated Disc

Clinical Trials on Nucleoplasty

3
Subscribe